Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2011 2
2012 3
2013 6
2014 7
2015 9
2016 10
2017 11
2018 16
2019 11
2020 20
2021 20
2022 10
2023 21
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Introduction.
Honda K, Masutani K. Honda K, et al. Among authors: masutani k. Nephron. 2020;144 Suppl 1:1. doi: 10.1159/000511269. Epub 2020 Dec 1. Nephron. 2020. PMID: 33260190 Free article. No abstract available.
Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Ogata H, et al. JAMA. 2021 May 18;325(19):1946-1954. doi: 10.1001/jama.2021.4807. JAMA. 2021. PMID: 34003226 Free PMC article. Clinical Trial.
Secondary renal amyloidosis associated with asbestos-related pleuropulmonary diseases.
Shibata R, Ozaki T, Tada K, Aoyama T, Watanabe M, Himuro N, Takahashi K, Ito K, Yasuno T, Miyake K, Masutani K, Uesugi N, Nabeshima K, Nakashima H. Shibata R, et al. Among authors: masutani k. CEN Case Rep. 2020 Nov;9(4):385-391. doi: 10.1007/s13730-020-00493-7. Epub 2020 Jun 13. CEN Case Rep. 2020. PMID: 32535843 Free PMC article. Review.
Effect of Low-Density Lipoprotein Apheresis on Quality of Life in Patients with Diabetes, Proteinuria, and Hypercholesterolemia.
Hara A, Wada T, Muso E, Maruyama S, Kato S, Furuichi K, Yoshimura K, Toyama T, Sakai N, Suzuki H, Tsukamoto T, Miyazaki M, Sato E, Abe M, Shibagaki Y, Narita I, Goto S, Sakamaki Y, Yokoyama H, Mori N, Tanaka S, Yuzawa Y, Hasegawa M, Matsubara T, Wada J, Tanabe K, Masutani K, Abe Y, Tsuruya K, Fujimoto S, Iwatsubo S, Tsuda A, Suzuki H, Kasuno K, Terada Y, Nakata T, Iino N, Sofue T, Miyata H, Nakano T, Ohtake T, Kobayashi S; LICENSE study group. Hara A, et al. Among authors: masutani k. Blood Purif. 2023;52(4):373-381. doi: 10.1159/000527900. Epub 2022 Dec 15. Blood Purif. 2023. PMID: 36521435
Severe disseminated infection by hypermucoviscous Klebsiella pneumoniae successfully treated by intensive therapy with continuous hemodiafiltration using AN69ST: A case report and review of the literature.
Tada K, Shibata R, Nakamura T, Kawaguchi Y, Nakano Y, Ishii H, Ura K, Yamada H, Maekawa S, Ito K, Masutani K. Tada K, et al. Among authors: masutani k. J Infect Chemother. 2023 Nov;29(11):1075-1080. doi: 10.1016/j.jiac.2023.07.006. Epub 2023 Jul 13. J Infect Chemother. 2023. PMID: 37451619 Retracted. Review.
125 results